ANDA 75964, held by Sun Pharm Inds Inc. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 75964 (Tramadol Hydrochloride), held by Sun Pharm Inds Inc, was first approved by FDA on Jun 19, 2002, with 17 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 19, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride50MG · tablet;oral | Tramadol Hydrochloride | Rx |
| Jun 18, 2026 | Supplement 48REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 47Labeling · Standard review | Approved | None posted |
| Dec 15, 2025 | Supplement 45Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 46REMS | Approved | None posted |
| Jan 10, 2024 | Supplement 43Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 42Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 41Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 36Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 35Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 32Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 29Labeling · Standard review | Approved | None posted |
| Sep 6, 2022 | Supplement 27Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 31REMS | Approved | None posted |
| Oct 15, 2015 | Supplement 25Labeling · Standard review | Approved | None posted |
| Nov 22, 2010 | Supplement 16Labeling | Approved | None posted |
| Jun 16, 2003 | Supplement 2Labeling | Approved | None posted |
| Sep 27, 2002 | Supplement 5Labeling | Approved | None posted |
| Jun 19, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters